Livongo Health (NASDAQ:LVGO) has been given a consensus rating of “Buy” by the ten brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $44.20.

Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. assumed coverage on shares of Livongo Health in a research note on Monday, August 19th. They issued an “overweight” rating and a $43.00 target price for the company. KeyCorp assumed coverage on shares of Livongo Health in a research note on Monday, August 19th. They issued an “overweight” rating and a $46.00 target price for the company. Goldman Sachs Group assumed coverage on shares of Livongo Health in a research note on Monday, August 19th. They issued a “buy” rating and a $43.00 target price for the company. Chardan Capital assumed coverage on shares of Livongo Health in a research note on Friday, August 16th. They issued a “neutral” rating and a $40.00 target price for the company. Finally, Needham & Company LLC began coverage on shares of Livongo Health in a research note on Monday, August 19th. They issued a “buy” rating and a $42.00 target price for the company.

In other Livongo Health news, major shareholder Ab (Publ) Kinnevik purchased 3,141,795 shares of Livongo Health stock in a transaction dated Monday, July 29th. The shares were bought at an average cost of $28.00 per share, for a total transaction of $87,970,260.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Hemant Taneja purchased 2,678,571 shares of Livongo Health stock in a transaction dated Monday, July 29th. The stock was acquired at an average price of $28.00 per share, for a total transaction of $74,999,988.00. The disclosure for this purchase can be found here. Insiders have acquired a total of 5,826,366 shares of company stock worth $162,980,808 over the last quarter.

Shares of Livongo Health stock traded up $0.48 during trading hours on Friday, hitting $25.76. The company’s stock had a trading volume of 111,665 shares, compared to its average volume of 964,200. Livongo Health has a 1-year low of $22.88 and a 1-year high of $45.68.

Livongo Health (NASDAQ:LVGO) last announced its earnings results on Thursday, September 5th. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.29). The firm had revenue of $40.90 million for the quarter, compared to analyst estimates of $39.74 million. The firm’s quarterly revenue was up 155.6% compared to the same quarter last year. Research analysts anticipate that Livongo Health will post -0.68 EPS for the current fiscal year.

About Livongo Health

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Further Reading: Outperform Rating

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.